Latest News in the pharma Industry

All

Selectchemie AG enters distribution agreement with Novo Nordisk Pharmatech A/S

Selectchemie AG enters distribution agreement with Novo Nordisk Pharmatech A/S

15 Sep 2017

Selectchemie AG and Novo Nordisk Pharmatech A/S have entered into a distribution agreement for Pharmaceutical Grade Quaternary Ammonium Compounds into the Pharmaceutical, Over-the-Counter (OTC), and Personal Care Markets for Eastern Europe, Switzerla...

Read more 
Fully modernized facility for the production of API

Fully modernized facility for the production of API

15 Sep 2017

We are proud to announce that a fully modernized facility for the production of active pharmaceutical ingredients (API) has been put into operation to meet our customers’ continuously growing requirements as regards quality and quantity.

Read more 
New clinical study shows that Probi’s probiotics support the immune system and may delay the onset of gluten intolerance in children

New clinical study shows that Probi’s probiotics support the immune system and may delay the onset of gluten intolerance in children

14 Sep 2017

A randomized, double-blind, placebo-controlled intervention trial has evaluated the effect of probiotics from Probi in children genetically predisposed for gluten intolerance (Celiac Disease). The results show that the probiotics have a suppressing ...

Read more 
Emulsifying, encapsulating and eliminating in one go

Emulsifying, encapsulating and eliminating in one go

14 Sep 2017

Ear health and hygiene with a novel twist.

Read more 
Building on shaky foundations? 'No way' says Sartorius

Building on shaky foundations? 'No way' says Sartorius

13 Sep 2017

Award-winning building protected by special construction against vibration and temperature fluctuations.

Read more 
Bosch subsidiary opens it doors to include biotech companies in need of GMP services

Bosch subsidiary opens it doors to include biotech companies in need of GMP services

13 Sep 2017

Valicare helps Swedish start-up to standardize processes in compliance with GMP.

Read more 
BIOSEARCH LIFE WILL BE INVOLVED IN THE PREMIUM PROJECT, APPROVED BY EUROPEAN COMMISSION.

BIOSEARCH LIFE WILL BE INVOLVED IN THE PREMIUM PROJECT, APPROVED BY EUROPEAN COMMISSION.

12 Sep 2017

The European Commission has recently announced the approval of the PREMIUM proposal: “Preservation of microorganisms by understanding the protective mechanisms of oligosaccharides”, submitted to the call: H2020-MSCA-RISE-2017.

The Marie Sklo...

Read more 
New service delivers streamlined pathway for Phase I trial milestones

New service delivers streamlined pathway for Phase I trial milestones

12 Sep 2017

Whether you're a small, virtual firm or Big Pharma, Recipharm Pathway to Clinic can remove the complexity out of first in human projects.

Read more 
Recipharm and CTC launch integrated first in human service

Recipharm and CTC launch integrated first in human service

12 Sep 2017

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestone...

Read more 
Opdivo + Yervoy combination demonstrated superior overall survival in patients with kidney cancer

Opdivo + Yervoy combination demonstrated superior overall survival in patients with kidney cancer

10 Sep 2017

The combination therapy reduced the risk of death by 37% versus standard of care, sunitinib, in intermediate- and poor-risk patients.

Read more 
FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen

FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen

10 Sep 2017

Warning letter cites Meridian Medical Technologies' failure to thoroughly investigate multiple serious component and product failures of EpiPen products.

Read more 
Monthly migraine days significantly reduced with erenumab

Monthly migraine days significantly reduced with erenumab

10 Sep 2017

The drug is the first and only fully human monoclonal antibody of its kind, uniquely designed to specifically block the CGRP receptor, which plays a critical role in activation of migraine.

Read more